Printer Friendly

Articles from MondayMorning (April 27, 2009)

1-28 out of 28 article(s)
Title Author Type Words
A Schering-Plough Corp (Kenilworth NJ) drug knocked the hepatitis C virus down to undetectable levels in three-fourths of patients in a mid-stage study, twice the effectiveness seen with standard treatments, researchers said. Brief article 304
Amerisourcebergen Inc. Brief article 187
Amgen Q1 profit falls as recession hits top-selling drug. Brief article 285
Atritech Inc. Brief article 102
Boston Scientific posts Q1 net loss; stent sales rise. Financial report 284
Center for Reproductive Rights. Brief article 136
Earnings watch: Hospital operator Tenet Healthcare Corp. (Dallas TX) said it expects to swing to a profit in the first quarter on cost controls and a modest decline in patient volume, sending its shares up 35% for the week. Financial report 265
Elan Corp Plc. Brief article 236
Genzyme Corp (Cambridge MA), the world's largest maker of enzyme therapies for genetic disorders, reported first-quarter profit below analysts' estimates. Financial report 182
Glaxo first-quarter hit by generics in US market. Brief article 234
Glaxo to buy Stiefel Labs; adds skin drugs. Brief article 286
Hormone replacement therapy may raise a woman's risk of breast cancer and heart disease but it lowers her risk of colon cancer, according to two studies released last week. Brief article 253
Johnson & Johnson. Brief article 114
Kathleen Sebelius's nomination to be Health and Human Services secretary cleared a Senate panel last week, bringing President Barack Obama closer to filling his last cabinet vacancy with an advocate for overhauling medical care. Brief article 295
Lilly's net income rises on new ImClone revenue. Brief article 299
Markets: investors set aside some of their worries about banks and the economy Friday after the government unveiled its methods for testing the health of banks. Brief article 327
Medical stock spotlight. Financial report 349
Merck Q1 profit falls as Schering-Plough reports gains. Financial report 415
Novartis Q1 profit beats estimates. Financial report 226
Quest Diagnostics Inc (Madison NJ) said its quarterly profit rose nearly 20% as it controlled costs and its clinical testing revenue remained steady, and it raised its 2009 earnings outlook. Financial report 179
Saint Jude Medical Inc. Brief article 170
St. Jude Medical Inc. Brief article 115
Stryker Corp (Kalamazoo MI), a maker of medical implants and other products, posted a drop in quarterly net income and lowered its outlook for full-year sales and earnings, citing weak demand for some products and procedures. Financial report 233
The results of a study published in the American Journal of Medicine suggest there is an association between aspirin use and a decreased risk of developing type 2 diabetes. Brief article 161
Vertex Pharmaceutical Inc's (Cambridge MA) experimental hepatitis C drug telaprevir wiped out signs of the infection in half of patients with hard-to-treat forms of the disease in a yearlong study. Brief article 242
Weekly key rates. Brief article 118
Weekly stock performance. Statistical table 459
WellPoint Inc. Brief article 238

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters